Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Role of miRNAs in tumor and endothelial cell interactions during tumor progression.

Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira LC, Paoletti C, Baruffaldi D, Penna E, Taverna D.

Semin Cancer Biol. 2019 Aug 3. pii: S1044-579X(19)30169-5. doi: 10.1016/j.semcancer.2019.07.024. [Epub ahead of print] Review.

PMID:
31386907
2.

Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.

Dettori D, Orso F, Penna E, Baruffaldi D, Brundu S, Maione F, Turco E, Giraudo E, Taverna D.

Mol Ther. 2018 Aug 1;26(8):2008-2018. doi: 10.1016/j.ymthe.2018.05.020.

3.

The long intergenic non-coding RNA CCR492 functions as a let-7 competitive endogenous RNA to regulate c-Myc expression.

Maldotti M, Incarnato D, Neri F, Krepelova A, Rapelli S, Anselmi F, Parlato C, Basile G, Dettori D, Calogero R, Oliviero S.

Biochim Biophys Acta. 2016 Oct;1859(10):1322-32. doi: 10.1016/j.bbagrm.2016.06.010. Epub 2016 Jun 23.

4.

miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.

Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D.

Cancer Res. 2016 Sep 1;76(17):5151-62. doi: 10.1158/0008-5472.CAN-15-1322. Epub 2016 Jun 21.

5.

Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.

Consolino L, Longo DL, Dastrù W, Cutrin JC, Dettori D, Lanzardo S, Oliviero S, Cavallo F, Aime S.

Int J Cancer. 2016 Jul 15;139(2):404-13. doi: 10.1002/ijc.30073. Epub 2016 Mar 29.

6.

TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues.

Neri F, Incarnato D, Krepelova A, Dettori D, Rapelli S, Maldotti M, Parlato C, Anselmi F, Galvagni F, Oliviero S.

Nucleic Acids Res. 2015 Aug 18;43(14):6814-26. doi: 10.1093/nar/gkv392. Epub 2015 Apr 29.

7.

AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs.

Collino F, Bruno S, Incarnato D, Dettori D, Neri F, Provero P, Pomatto M, Oliviero S, Tetta C, Quesenberry PJ, Camussi G.

J Am Soc Nephrol. 2015 Oct;26(10):2349-60. doi: 10.1681/ASN.2014070710. Epub 2015 Apr 21.

8.

Snai1 promotes ESC exit from the pluripotency by direct repression of self-renewal genes.

Galvagni F, Lentucci C, Neri F, Dettori D, De Clemente C, Orlandini M, Anselmi F, Rapelli S, Grillo M, Borghi S, Oliviero S.

Stem Cells. 2015 Mar;33(3):742-50. doi: 10.1002/stem.1898.

9.

TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Neri F, Dettori D, Incarnato D, Krepelova A, Rapelli S, Maldotti M, Parlato C, Paliogiannis P, Oliviero S.

Oncogene. 2015 Aug 6;34(32):4168-76. doi: 10.1038/onc.2014.356. Epub 2014 Nov 3.

10.

The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.

Olivero M, Dettori D, Arena S, Zecchin D, Lantelme E, Di Renzo MF.

Oncotarget. 2014 Aug 15;5(15):5992-6002.

11.

FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription.

Evellin S, Galvagni F, Zippo A, Neri F, Orlandini M, Incarnato D, Dettori D, Neubauer S, Kessler H, Wagner EF, Oliviero S.

Mol Cell Biol. 2013 Mar;33(6):1198-209. doi: 10.1128/MCB.01054-12. Epub 2013 Jan 14.

12.

Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity.

Leite de Oliveira R, Deschoemaeker S, Henze AT, Debackere K, Finisguerra V, Takeda Y, Roncal C, Dettori D, Tack E, Jönsson Y, Veschini L, Peeters A, Anisimov A, Hofmann M, Alitalo K, Baes M, D'hooge J, Carmeliet P, Mazzone M.

Cancer Cell. 2012 Aug 14;22(2):263-77. doi: 10.1016/j.ccr.2012.06.028.

13.

Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.

Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, Schmidt T, Loges S, Albrecht I, Jonckx B, Vinckier S, Van Steenkiste C, Tugues S, Rolny C, De Mol M, Dettori D, Hainaud P, Coenegrachts L, Contreres JO, Van Bergen T, Cuervo H, Xiao WH, Le Henaff C, Buysschaert I, Kharabi Masouleh B, Geerts A, Schomber T, Bonnin P, Lambert V, Haustraete J, Zacchigna S, Rakic JM, Jiménez W, Noël A, Giacca M, Colle I, Foidart JM, Tobelem G, Morales-Ruiz M, Vilar J, Maxwell P, Vinores SA, Carmeliet G, Dewerchin M, Claesson-Welsh L, Dupuy E, Van Vlierberghe H, Christofori G, Mazzone M, Detmar M, Collen D, Carmeliet P.

Cell. 2010 Apr 2;141(1):178-90. doi: 10.1016/j.cell.2010.02.039.

14.

Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.

Costa B, Dettori D, Lorenzato A, Bardella C, Coltella N, Martino C, Cammarata C, Carmeliet P, Olivero M, Di Renzo MF.

FASEB J. 2010 Aug;24(8):2680-8. doi: 10.1096/fj.09-146928. Epub 2010 Mar 30.

PMID:
20354140
15.

VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.

Koch M, Dettori D, Van Nuffelen A, Souffreau J, Marconcini L, Wallays G, Moons L, Bruyère F, Oliviero S, Noel A, Foidart JM, Carmeliet P, Dewerchin M.

J Pathol. 2009 Nov;219(3):356-64. doi: 10.1002/path.2605.

16.

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Mazzone M, Dettori D, de Oliveira RL, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, de Almodovar CR, De Smet F, Vinckier S, Aragonés J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P.

Cell. 2009 Mar 6;136(5):839-851. doi: 10.1016/j.cell.2009.01.020. Epub 2009 Feb 12.

17.

The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.

Bardella C, Dettori D, Olivero M, Coltella N, Mazzone M, Di Renzo MF.

Clin Cancer Res. 2007 Apr 1;13(7):2191-8.

Supplemental Content

Loading ...
Support Center